AAD 2026Abstract 73591
Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% Provides Improvements in Caregiver-Reported Outcomes That are Maintained Long Term
Results for Patients Aged 2–5 years With Mild-to-Moderate Atopic Dermatitis in the INTEGUMENT-OLE Trial
Eichenfield L, Boguniewicz M, Lee LW, Browning J, Chih-Ho Hong H, Serrao R, Prajapati VH, Friedman A, Seal MS, Hanna D, Simpson E
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1279 · Not in PubMed: details from Crossref